Evaluation of hexamethylmelamine in murine renal cell carcinoma model

P. D. Williams, J. Burdick, G. P. Murphy

Research output: Contribution to journalArticlepeer-review

Abstract

An evaluation of hexamethylmelamine was attempted to establish its therapeutic value in the treatment of renal cell carcinoma. A murine renal cell adenocarcinoma model was treated with 3 dosage levels of hexamethylmelamine at an early and late stage of disease occurrence. From the results observed and analyzed, it seems unlikely that hexamethylamine may be of clinical benefit in the treatment of renal carcinoma in man.

Original languageEnglish (US)
Pages (from-to)399-407
Number of pages9
JournalRES.COMMUN.CHEM.PATH.PHARMACOL.
Volume7
Issue number2
StatePublished - Jan 1 1974
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Evaluation of hexamethylmelamine in murine renal cell carcinoma model'. Together they form a unique fingerprint.

Cite this